Colon-targeted celecoxib-loaded Eudragit^® S100-coated poly-ϵ-caprolactone microparticles: Preparation, characterization and in vivo evaluation in rats

References

• Abdallah M, Yuichi T, Hirofumi T. (2009). pH-Sensitive nanospheres for colon-specific drug delivery in experimentally induced colitis rat model. Eur J Pharm Biopharm, 72, 1–8.
   PubMed Web of Science ®Google Scholar
• Abdelbary GA, Tadros MI. (2008). Design and in vitro/in vivo evaluation of novel nicorandil extended release matrix tablets based on hydrophilic interpolymer complexes and a hydrophobic waxy polymer. Eur J Pharm Biopharm, 69, 1019–28.
   PubMed Web of Science ®Google Scholar
• Ali J, Tyagi P, Ahuja A, Baboota S, Hasan S. (2007). Development and evaluation of a gastroretentive drug delivery system for the low-absorption-window drug celecoxib. PDA J Pharm Sci Technol, 61(2), 88–96.
   PubMedGoogle Scholar
• Ardizzone S, Bianchi Porro G. (1998). A practical guide to the management of distal ulcerative colitis. Drugs, 55, 519–42.
   PubMed Web of Science ®Google Scholar
• Ashford M, Fell JT, Attwood D, Woodhead PJ. (1993). An in vitro investigation into the suitability of pH-dependent polymers for colonic targeting. Int J Pharm, 91, 241–45.
   Web of Science ®Google Scholar
• Barbato F, Rotonda MI, Maglio G, Palumo R, Quaglia F. (2001). Biodegradable microspheres of a novel segmented polyether-ester-amides based on poly-ϵ-caprolactone for the delivery of bioactive compounds. Biomaterials, 22, 1371–78.
   PubMed Web of Science ®Google Scholar
• Campieri M, Ferguson A, Doe W, Persson T, Nilsson LG. (1997). Oral budesonide is as effective as oral prednisolone in active Crohn’s disease. The Global Budesonide Study Group. Gut, 41, 209–14.
   PubMed Web of Science ®Google Scholar
• Castellanos IJ, Carrasquillo KG, de Jesus Lopez J, Alvarez M, Griebenow K. (2001). Encapsulation of bovine serum albumin in poly(lactide-co-glycolide) microspheres by the solid-in-oil-in-water technique. J Pharm Pharmacol, 53, 167–78.
   PubMed Web of Science ®Google Scholar
• Cheng SY, Yuen MC, Lam PL, Gambari R, Wong RS, Cheng GY, Lai PB, Tong SW, Chan KW, Lau FY, Kok SH, Lam KH, Chui CH. (2010). Synthesis, characterization and preliminary analysis of in vivo biological activity of chitosan/celecoxib microcapsules. Bioorg Med Chem Lett, 20(14), 4147–4151.
   PubMed Web of Science ®Google Scholar
• Chourasia MK, Jain SK. (2003). Pharmaceutical approaches to colon targeted drug delivery systems. J Pharm Sci, 6(1), 33–66.
   Web of Science ®Google Scholar
• de Heer P, Sandel MH, Guertens G, de Boeck G, Koudijs MM, Nagelkerke JF, Junggeburt JM, de Bruijn EA, van de Velde CJ, Kuppen PJ. (2008). Celecoxib inhibits growth of tumors in a syngeneic rat liver metastases model for colorectal cancer. Cancer Chemother Pharmacol, 62(5), 811–19.
   PubMed Web of Science ®Google Scholar
• Fu X, Ping Q, Gao Y. (2005). Effects of formulation factors on encapsulation efficiency and release behavior in vitro of huperzine A-PLGA microspheres. J Microencapsul, 22, 705–14.
   PubMed Web of Science ®Google Scholar
• Higuchi T. (1963). Mechanism of sustained action medication. J Pharm Sci, 52, 1145–49.
   PubMed Web of Science ®Google Scholar
• Homar M, Ubrich N, El Ghazouani F, Kristl J, Kerc J, Maincent P. (2007). Influence of polymers on the bioavailability of microencapsulated celecoxib. J Microencapsul, 24(7), 621–633.
   PubMed Web of Science ®Google Scholar
• Hu LD, Liu Y, Tang X, Zhang Q. (2006). Preparation and in vitro/in vivo evaluation of sustained-release metformin hydrochloride pellets. Eur J Pharm Biopharm, 64, 185–92.
   PubMed Web of Science ®Google Scholar
• Imaly JA, Linn S. (1988). DNA damage and oxygen radical toxicity. Science, 240, 1302–9.
   PubMed Web of Science ®Google Scholar
• Kondo H, Sharma RK, Mishra AK, Chuttani K, Murthy RR. (2005). Albumin microspheres as carriers for the antiarthritic drug celecoxib. AAPS PharmSciTech, 6 (1), E65–73.
   PubMedGoogle Scholar
• Kondo N, Iwao T, Hirai K, Fukuda M, Yamanouchi K, Yokoyama K, Miyaji M, Ishihara Y, Kon K, Ogawa Y, Mayumi T. (1994). Improved oral absorption of enteric coprecipitates of a poorly soluble drug. J Pharm Sci, 4(83), 566–70.
   Google Scholar
• Korsmeyer RW, Peppas NA. (1981). Effect of the morphology of hydrophilic polymeric matrices on the diffusion and release of water soluble drugs. J Membr Sci, (9), 211–27.
   Google Scholar
• Krishnamachari Y, Madan P, Lin S. (2007). Development of pH- and time dependent oral microparticles to optimize budesonide delivery to ileum and colon. Int J Pharm, 348, 238–47.
   Google Scholar
• Lamprecht A, Schafer U, Lehr CM. (2001). Size-dependent bioadhesion of micro- and nanoparticulate carriers to the inflamed colonic mucosa. Pharm Res, 18, 788–93.
   PubMed Web of Science ®Google Scholar
• Mahadevan U, Loftus EV Jr, Tremaine WJ, Sandborn WJ. (2002). Safety of selective cyclooxygenase-2 inhibitors in inflammatory bowel disease. Am J Gastroenterol, 97(4), 910–14.
   PubMed Web of Science ®Google Scholar
• Meissner Y, Pellequer Y, Lamprecht A. (2006). Nanoparticles in inflammatory bowel disease: particle targeting versus pH-sensitive delivery. Int J Pharm, 316, 138–43.
   PubMed Web of Science ®Google Scholar
• Nakase H, Okazaki K, Tabata Y, Uose S, Ohana M, Uchida K, Matsushima Y, Kawanami C, Oshima C, Ikada Y, Chiba T. (2000). Development of an oral drug delivery system targeting immune-regulating cells in experimental inflammatory bowel disease: a new therapeutic strategy. J Pharmacol Exp Ther, 292, 15–21.
   PubMed Web of Science ®Google Scholar
• Niederberger E, Tegeder I, Vetter G, Schmidtko A, Schmidt H, Euchenhofer C, Bräutigam L, Grösch S, Geisslinger G. (2001). Celecoxib loses its anti-inflammatory efficacy at high doses through activation of NF-κB. The FASEB J, 15, 1622–24.
   PubMed Web of Science ®Google Scholar
• Paulson SK, Vaughn MB, Jessen SM, Lawal Y, Gresk CJ, Yan B, Maziasz TJ, Cook CS, Karim A. (2001). Pharmacokinetics of celecoxib after oral administration in dogs and humans: effect of food and site of absorption. J Pharmacol Exp Ther, 297 (2), 638–645.
   PubMed Web of Science ®Google Scholar
• Passerini N, Perissutti B, Albertini B, Voinovich D, Moneghini M, Rodriguez L. (2003). Controlled release of verapamil hydrochloride from waxy microparticles prepared by spray congealing. J Control Release, 88(2), 263–275.
   PubMed Web of Science ®Google Scholar
• Raffin RP, Colomé LM, Guterres SS, Pohlmann AR. (2007). Enteric Controlled-Release Pantoprazole-Loaded Microparticles Prepared by Using Eudragit S100 and Poly(ε-caprolactone) Blend. Pharm Dev Technology, 12(5), 463–71.
   PubMed Web of Science ®Google Scholar
• Rodriguez M, Vila-Jato JL, Torres D. (1998). Design of new multiparticulate system for potential site specific and controlled drug delivery to the colonic region. J Control Rel, 55, 67–77.
   PubMed Web of Science ®Google Scholar
• Simmonds NJ, Rampton DS. (1994). Inflammatory bowel disease: a radical view. Gut, 34, 861–5.
   Google Scholar
• Sinha VR, Bhinge JR, Kumria R, Kumar M. (2006). Development of pulsatile systems for targeted drug delivery of celecoxib for prophylaxis of colorectal cancer. Drug Deliv, 13(3), 221–5.
   PubMed Web of Science ®Google Scholar
• Sinha VR, Bansal K, Kaushik R, Kumria R, Trehan A. (2004). Poly-ϵ-caprolactone microspheres and nanospheres: an overview. Int J Pharm, 278, 1–23.
   PubMed Web of Science ®Google Scholar
• Tan A, Simovic S, Davey AK, Rades T, Prestidge CA. (2009). Silica-lipid hybrid (SLH) microcapsules: A novel oral delivery system for poorly soluble drugs. J Control Rel, 134, 62–70.
   PubMed Web of Science ®Google Scholar
• Thakkar H, Sharma RK, Mishra AK, Chuttani K, Murthy RR. (2005). Albumin microspheres as carriers for the antiarthritic drug celecoxib. AAPS PharmSciTech, 20;6(1), E65–73.
   Google Scholar
• Thakkar H, Sharma RK, Mishra AK, Chuttani K, Murthy RS. (2004). Celecoxib incorporated chitosan microspheres: in vitro and in vivo evaluation. J Drug Target, 12(9-10), 549–557.
   PubMed Web of Science ®Google Scholar
• Yehia SA, Elshafeey AH, Sayed I, Shehata AH. (2009). Optimization of budesonide compression-coated tablets for colonic delivery. AAPS PharmSciTech, 10(1), 147–57.
   PubMed Web of Science ®Google Scholar
• Zvonar A, Kristl J, Kerc J, Grabnar PA.(2009). High celecoxib-loaded nanoparticles prepared by a vibrating nozzle device. J Microencapsul, 26(8), 748–759.
   PubMed Web of Science ®Google Scholar